Hydromorphone Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 11/01/2017. Reported reason: Other
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-4264-01
- Dosage Form
- Injection
- Presentation
- Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)
- Initial Posting
- 11/01/2017
- Revised Date
Reason
Other